Previous 10 | Next 10 |
The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with this event. For further details see: Cardiovascular Systems (CSII) Presents At Oppenheimer 31st Annual Healthcare Conference - Slideshow
Cardiovascular Systems ([[CSII]] +0.1%) has announced the treatment of first patients in the U.S. with the company’s WIRION Embolic Protection System.A distal embolic protection filter, WIRION is used to capture thrombus and debris linked to peripheral vascular intervention procedures,...
Device offers a streamlined approach for lower extremity embolic protection Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and...
The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with this event. For further details see: Cardiovascular Systems (CSII) Presents At Raymond James 42nd Annual Institutional Investors Conference - Slideshow
The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with this event. For further details see: Cardiovascular Systems (CSII) Presents at SVB Leerink 10th Annual Global Healthcare Conference - Slideshow
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host inve...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in Europe has been trea...
Image source: The Motley Fool. Cardiovascular Systems Inc (NASDAQ: CSII) Q2 2021 Earnings Call Feb 3, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Cardiovascular Systems Inc (CSII) Q2 2021 Earnings Call Transcrip...
Cardiovascular Systems, Inc. (CSII) Q2 2021 Results Conference Call February 3, 2021 4:30 PM ET Company Participants Jack Nielsen - Vice President, Investor Relations and Corporate Communications Scott Ward - Chairman, President, Chief Executive Officer Rhonda Robb - Chief Operating Officer J...
Cardiovascular Systems (CSII): FQ2Revenue of $64.2M (-6.0% Y/Y) misses by $1.31M.Press Release For further details see: Cardiovascular Systems misses on revenue
News, Short Squeeze, Breakout and More Instantly...
Cardiovascular Systems Inc. Company Name:
CSII Stock Symbol:
NASDAQ Market:
Cardiovascular Systems Inc. Website:
Cytek Biosciences Set to Join S&P SmallCap 600 Cytek Biosciences Set to Join S&P SmallCap 600 PR Newswire NEW YORK , April 25, 2023 /PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P S...
Largest randomized coronary atherectomy trial ever conducted Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today...
NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: INDUS Realty Trust, Inc. (NASDAQ:I...